We are live on ! Find out more
OPK icon

Opko Health

232 hedge funds and large institutions have $855M invested in Opko Health in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 65 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 65

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.49% less ownership

Funds ownership: 23.53%23.04% (-0.49%)

5% less funds holding

Funds holding: 245232 (-13)

19% less capital invested

Capital invested by funds: $1.05B → $855M (-$196M)

26% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 42

73% less call options, than puts

Call options by funds: $10.9M | Put options by funds: $40.7M

Holders
232
Holders Change
-13
Holders Change %
-5.31%
% of All Funds
5.78%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
31
Increased
80
Reduced
65
Closed
42
Calls
$10.9M
Puts
$40.7M
Net Calls
-$29.8M
Net Calls Change
+$16.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
176
Comerica Bank
Texas
$84K +$1.96K +280 +2%
ASN
177
Advisory Services Network
Georgia
$84K +$89.4K +12,750 New
Zurich Cantonal Bank
178
Zurich Cantonal Bank
Switzerland
$82K +$10K +1,427 +13%
TSS
179
Two Sigma Securities
New York
$81K +$86.8K +12,383 New
SGK
180
Steigerwald Gordon & Koch
Virginia
$77K
Russell Investments Group
181
Russell Investments Group
United Kingdom
$75K -$30.1K -4,294 -27%
WJA
182
Williams Jones & Associates
New York
$74K
FNBT
183
FineMark National Bank & Trust
Florida
$73K +$5.96K +850 +8%
MLICM
184
Metropolitan Life Insurance Company (MetLife)
New York
$70K -$72.6K -10,360 -49%
RBC
185
Ronald Blue & Co
Georgia
$68K
Simplex Trading
186
Simplex Trading
Illinois
$68K +$65K +9,268 +803%
GCIA
187
Gabelli & Co Investment Advisers
New York
$66K
AIG
188
American International Group
New York
$48K -$1.18K -168 -2%
PNC Financial Services Group
189
PNC Financial Services Group
Pennsylvania
$45K -$12.4K -1,771 -21%
FDCDDQ
190
Federation des caisses Desjardins du Quebec
Quebec, Canada
$44.5K +$47.4K +6,759 New
PWM
191
Perigon Wealth Management
California
$44K +$841 +120 +2%
QI
192
QS Investors
New York
$41K
BNP Paribas Financial Markets
193
BNP Paribas Financial Markets
France
$40.7K +$6.43K +918 +17%
MRCM
194
M&R Capital Management
New Jersey
$37K
Bessemer Group
195
Bessemer Group
New Jersey
$33K -$1.95K -278 -5%
PMFA
196
Plante Moran Financial Advisors
Michigan
$27K
RFA
197
Reilly Financial Advisors
California
$26K
Fifth Third Bancorp
198
Fifth Third Bancorp
Ohio
$24K
Nisa Investment Advisors
199
Nisa Investment Advisors
Missouri
$22K -$61.7K -8,800 -73%
Northwestern Mutual Wealth Management
200
Northwestern Mutual Wealth Management
Wisconsin
$16K

OPK Hedge Fund Activity: Q2 2017 in Review

232 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2017, worth a combined $855M — down 19% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of OPK and 31 opened new positions — a net loss of 11 holders — while 65 trimmed existing stakes and 80 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $11.3M. The largest seller was Mivtachim The Workers Social Insurance Fund, cutting an estimated $13M.

  • 232 institutional investors held Opko Health (OPK) as of Q2 2017, down from 245 in Q1 2017.
  • Funds reported $855M of Opko Health stock for Q2 2017, down 19% quarter-over-quarter.
  • 31 funds opened new Opko Health positions in Q2 2017 and 42 closed out, a net change of -11 holders.
  • The largest Opko Health buyer in Q2 2017 was Renaissance Technologies, an estimated $11.3M added.
  • The largest Opko Health seller in Q2 2017 was Mivtachim The Workers Social Insurance Fund, an estimated $13M sold.

Based on aggregated 13F filings for Q2 2017.